Skip to Main Content
Navigation

New England Journal of Medicine’s mobile offerings

New England Journal of Medicine mobile app logoThis week the New England Journal of Medicine (NEJM) released an iPad app that allows journal and NEJM.org subscribers to:

  • Download the new issue each Thursday, and store all downloaded issues in a personal library
  • Bookmark articles, images & figures
  • Watch clinical medicine videos
  • Listen to an audio summary for each issue
  • Capture and save article notes, and even share them via email, Facebook & Twitter

Non-subscribers view a fully functional free issue, preview the table of contents for each issue and read Online First articles. App-only subscriptions of the NEJM are $14.99 per month, and purchase of a single issue is $5.99 each. At first glance, it does not yet appear that institutional subscribers can use this app to access NEJM, which is a significant oversight. Many faculty, researchers and physicians here at the University of Utah rely on the NEJM, and if a clinical reference tool such as LexiComp can provide an institutional version of their software, so can a top-notch journal publisher.

In downloading the iPad app, I discovered the NEJM Career Center, an iPhone/iPad app that, like its website counterpart, will help physicians search listings of physician and locum tenens job listings by location, specialty or position type. It notifies users of new jobs that match their search criteria, and allows them to email or tweet jobs to themselves or their personal networks.

If you want to keep up on the latest researched published in NEJM, subscribe to their weekly audio summaries podcast, NEJM This Week. Each podcast is 20-25 minutes long, and includes new medical research findings, review articles, and editorial opinion pieces on topics related to biomedical science and clinical practice.

Do you use any of the NEJM apps? What do you like or dislike about them? Tell us about it!

This entry was posted in medicine, mobile and tagged , , , , , . Bookmark the permalink. Follow any comments here with the RSS feed for this post. Both comments and trackbacks are currently closed.

Comments are closed